LC-MS/MS analysis of plasma polyunsaturated fatty acids in type 2 diabetic patients after insulin analog initiation therapy

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Aslan, Mutay ^a   Özcan, Filiz ^a   Aslan, Ibrahim ^b   Yücel, Gültekin ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b Antalya Education and Research Hospital   (Turkey)

Author keywords

Diabetes mellitus; Insulin; Polyunsaturated fatty acids; Prostaglandin

Indexed keywords

ARACHIDONIC ACID; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; ICOSAPENTAENOIC ACID; INSULIN GLARGINE; INSULIN LISPRO; METFORMIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROSTAGLANDIN E; PROSTAGLANDIN E2; SULFONYLUREA;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DIABETIC PATIENT; DRUG EFFECT; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; EARLY INTERVENTION; ELECTROSPRAY MASS SPECTROMETRY; ENZYME IMMUNOASSAY; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

8,11,14-EICOSATRIENOIC ACID; ADULT; AGED; ARACHIDONIC ACID; CHROMATOGRAPHY, LIQUID; DIABETES MELLITUS, TYPE 2; DINOPROSTONE; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; MIDDLE AGED; TANDEM MASS SPECTROMETRY;

EID: 84887073039     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-169     Document Type: Article

References (33)

1. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Wild S, Roglic G, Green A, Sicree R, King H, Diabetes Care 2004 27 5 1047 1053 (Pubitemid 38579764)
2. The role of inflammatory cytokines in diabetic nephropathy. Navarro-González JF, Mora-Fernández C, J Am Soc Nephrol 2008 19 3 433 442 (Pubitemid 351355386)
3. Type 2 diabetes as an inflammatory disease. Donath MY, Shoelson SE, Nat Rev Immunol 2011 11 2 98 107
4. Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications. Börgeson E, Godson C, Front Immunol 2012 3 318
5. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Wall R, Ross RP, Fitzgerald GF, Stanton C, Nutr Rev 2010 68 5 280 289
6. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Serhan CN, Chiang N, Van Dyke TE, Nat Rev Immunol 2008 8 5 349 361 (Pubitemid 351595216)
7. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. González-Périz A, Horrillo R, Ferré N, Gronert K, Dong B, Morán-Salvador E, Titos E, Martínez-Clemente M, López-Parra M, Arroyo V, Clària J, FASEB J 2009 23 6 1946 1957
8. The use of ω-3 poly-unsaturated fatty acids in heart failure: a preferential role in patients with diabetes. Kazemian P, Kazemi-Bajestani SM, Alherbish A, Steed J, Oudit GY, Cardiovasc Drugs Ther 2012 26 4 311 320
9. Hormonal modulation of delta6 and delta5 desaturases: case of diabetes. Brenner RR, Prostaglandins Leukot Essent Fatty Acids 2003 68 2 151 162 (Pubitemid 36216479)
10. Low phospholipid arachidonic acid values in diabetic platelets. Jones DB, Carter RD, Haitas B, Mann JI, Br Med J (Clin Res Ed) 1983 286 6360 173 175
11. Polyunsaturated fatty acids in plasma and erythrocyte membrane lipids of diabetic children. Decsi T, Minda H, Hermann R, Kozári A, Erhardt E, Burus I, Molnár S, Soltész G, Prostaglandins Leukot Essent Fatty Acids 2002 67 4 203 210 (Pubitemid 35192163)
12. Fatty acid compositions of serum lipids, erythrocytes, and platelets in insulin-dependent diabetic women. Tilvis RS, Miettinen TA, J Clin Endocrinol Metab 1985 61 4 741 745 (Pubitemid 16248101)
13. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, Hellman R, Jellinger PS, Jovanovic LG, Levy P, Mechanick JI, Zangeneh F, Endocr Pract 2007 13 1 1 68
14. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Friedewald WT, Levy RI, Fredrickson DS, Clin Chem 1972 18 6 499 502
15. Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry. Valianpour F, Selhorst JJ, van Lint LE, van Gennip AH, Wanders RJ, Kemp S, Mol Genet Metab 2003 79 3 189 196 (Pubitemid 36809046)
16. Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients. Aslan I, Kucuksayan E, Aslan M, Lipids Health Dis 2013 24 12 54
17. The roles of essential fatty acids in the development of diabetic neuropathy and other complications of diabetes mellitus. Horrobin DF, Prostaglandins Leukot Essent Fatty Acids 1988 31 3 181 197
18. Short-term diabetic ketosis alters n-6 polyunsaturated fatty acid content in plasma phospholipids. Bassi A, Avogaro A, Crepaldi C, Pavan P, Zambon S, Marin R, Macdonald I, Manzato E, J Clin Endocrinol Metab 1996 81 4 1650 1653 (Pubitemid 26118606)
19. Polyunsaturated fatty acids in plasma lipids of diabetic children during and after diabetic ketoacidosis. Decsi T, Szabó E, Kozári A, Erhardt E, Marosvölgyi T, Soltész G, Acta Paediatr 2005 94 7 850 855 (Pubitemid 41044766)
20. Fatty acid desaturases in human adipose tissue: relationships between gene expression, desaturation indexes and insulin resistance. Sjögren P, Sierra-Johnson J, Gertow K, Rosell M, Vessby B, de Faire U, Hamsten A, Hellenius ML, Fisher RM, Diabetologia 2008 51 2 328 335
21. Depression of microsomal desaturation of linoleic to gamma-linolenic acid in the alloxan-diabetic rat. Mercuri O, Peluffo RO, Brenner RR, Biochim Biophys Acta 1966 116 2 409 411
22. Effect of insulin on the oxidative desaturation of a-linolenic, oleic and palmitic acids. Mercuri O, Peluffo RO, Brenner RR, Lipids 1967 2 3 284 285
23. Effects of diabetes and insulin on hepatic delta6 desaturase gene expression. Rimoldi OJ, Finarelli GS, Brenner RR, Biochem Biophys Res Commun 2001 283 2 323 326 (Pubitemid 32924691)
24. Comparative in vivo and in vitro study of the influence of experimental diabetes on rat liver linoleic acid delta 6- and delta 5-desaturation. Poisson JP, Enzyme 1985 34 1 1 14 (Pubitemid 16226910)
25. Polyunsaturated fatty acids, inflammation, and immunity. Calder PC, Lipids 2001 36 9 1007 1024 (Pubitemid 33065203)
26. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. Tilley SL, Coffman TM, Koller BH, J Clin Invest 2001 108 1 15 23 (Pubitemid 32634916)
27. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST, Proc Natl Acad Sci USA 2003 100 4 1751 1756 (Pubitemid 36254520)
28. Prostacyclin and pathogenesis of hemodynamic abnormalities of diabetic ketoacidosis in rats. Quyyumi AA, Iaffaldano R, Guerrero JL, Ryan CA, Powell WJ Jr, Axelrod L, Diabetes 1989 38 12 1585 1594 (Pubitemid 20006685)
29. T he effect of high-dose insulin analog initiation therapy on lipid peroxidation products and oxidative stress markers in type 2 diabetic patients. Tuzcu H, Aslan I, Aslan M, Oxid Med Cell Longev 2013 2013 513742
30. Importance of the omega-6/omega-3 balance in health and disease: evolutionary aspects of diet. Simopoulos AP, World Rev Nutr Diet 2011 102 10 21
31. Dietary substitution with an alpha-linolenic acid-rich vegetable oil increases eicosapentaenoic acid concentrations in tissues. Mantzioris E, James MJ, Gibson RA, Cleland LG, Am J Clin Nutr 1994 59 6 1304 1309
32. Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. Liou YA, King DJ, Zibrik D, Innis SM, J Nutr 2007 137 4 945 952 (Pubitemid 46596892)
33. Metabolism of alpha-linolenic acid in humans. Burdge GC, Prostaglandins Leukot Essent Fatty Acids 2006 75 3 161 168